Castle Biosciences CSTL Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's total liabilities?
- Castle Biosciences (CSTL) reported total liabilities of $86.39M in Q1 2026.
- How has Castle Biosciences's total liabilities changed year-over-year?
- Castle Biosciences's total liabilities increased by 40.7% year-over-year, from $61.41M to $86.39M.
- What is the long-term trend for Castle Biosciences's total liabilities?
- Over 5 years (2020 to 2025), Castle Biosciences's total liabilities has grown at a 35.4% compound annual growth rate (CAGR), from $23.64M to $107.68M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.